‌

US Patent 11975027 Tumoricidal and antimicrobial compositions and methods

Patent 11975027 was granted and assigned to ImmunityBio on May, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Barry J. Simon0

Hans G. Klingemann0

Date of Patent

May 7, 2024

0

Patent Application Number

175391550

Date Filed

November 30, 2021

0

Patent Citations

US Patent 10258649 Tumoricidal and antimicrobial compositions and methods

0

US Patent 7618817 Genetically modified human natural killer cell lines

0

US Patent 8034332 Interleukin-secreting natural killer cell lines and methods of use

0

US Patent 8067044 Cosmetic compositions containing an extract of leaves of the

0

US Patent 8313943 Genetically modified human natural killer cell lines

0

US Patent 10517895 Tumoricidal and antimicrobial compositions and methods

0

Patent Primary Examiner

David W Berke-Schlessel

0

Patent abstract

Provided herein are pharmaceutical compositions comprising tumoricidal and/or antimicrobial components isolated from the supernatant of NK-92 cell medium and methods of using the compositions for killing cancer cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11975027 Tumoricidal and antimicrobial compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.